Asian Patients with Stroke plus Atrial Fibrillation and the Dose of Non-Vitamin K Oral Anticoagulants
After recent randomized control trials (RCTs), non-vitamin K oral anticoagulants (NAOAs) are now widely being used in patients with atrial fibrillation (AF) worldwide. However, current guidelines for the use of NOACs in patients with AF are derived mostly using a Caucasian population and non-stroke...
Main Authors: | Oh Young Bang, Keun-Sik Hong, Ji Hoe Heo |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Stroke Society
2016-05-01
|
Series: | Journal of Stroke |
Subjects: | |
Online Access: | http://www.j-stroke.org/upload/pdf/jos-2016-00052.pdf |
Similar Items
-
New Oral Anticoagulants May Be Particularly Useful for Asian Stroke Patients
by: Oh Young Bang, et al.
Published: (2014-05-01) -
Non-vitamin K oral anticoagulants (NOACs) in patients with stroke and atrial fibrillation
by: Jovanović Dejana R.
Published: (2020-01-01) -
MRI screening for chronic anticoagulation in atrial fibrillation
by: Mark eFisher
Published: (2013-10-01) -
Current guidelines and prospects for using novel oral anticoagulants for nonvalvular atrial fibrillation
by: A. V. Fonyakin
Published: (2014-12-01) -
PHARMACODYNAMICS OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN THE ACUTE PERIOD OF ISCHEMIC STROKE
by: V. I. Petrov, et al.
Published: (2021-01-01)